Currently, there is no FDA-approved medication for stimulant use disorder.
To improve health outcomes, groups join forces to standardize race, ethnicity, language, sexual orientation, and gender identity data collection
COPD, or chronic obstructive pulmonary disease, is a serious lung condition that affects millions of people. Also known as emphysema or chronic bronchitis, COPD causes breathing...
The Foundation for a Smoke-Free World is inviting researchers to propose new analysis and educational programs to combat the widespread misconception among Indian doctors that nicotine...
The Company's At-a-Glance Report highlights its achievements and initiatives in advancing health equity while operating responsibly and sustainably in the communities it serves.
Treydora revolutionizes entertainment and training with NFT comics and VR education for healthcare.
Plans feature expanded money-saving benefits that matter most to members
Make a difference during Breast Cancer Awareness Month by taking action, supporting early detection, and accessing resources.
FDA grants marketing authorization for DNA test assessing predisposition for multiple cancer types.
FDA launches pilot program to accelerate rare disease therapies, improving communication between sponsors and FDA staff. #RareDiseaseTherapies #FDA #ClinicalTrials